Dr. Miller is an expert in the design validation and implementation of rapid and alternative microbiology methods. He has provided technical, regulatory, marketing, sales and strategic guidance to technology suppliers and end-users for many years. Dr. Miller can provide an in-depth understanding of FDA and EMA regulatory expectations for RMM validation, assist with validation protocols and act as your liaison when meeting with regulatory agencies.
As the owner of the educational website rapidmicromethods.com, Dr. Miller is also an excellent resource for providing on-site presentations and full-day training courses on RMMs implementation.
Are you considering implementing rapid micro methods but don't have the in-house expertise to champion these efforts? Are you designing a new RMM technology and want to develop a robust strategy for commercialization? Concerned about regulatory impact and return on investment? Our RMM expert can provide guidance and support in all of these areas, whether you are a supplier of new microbiology technologies or an end-user.
Dr. Miller teams with RMM customers to coordinate the initial assessment of rapid micro methods, recommends the best technology, and creates feasibility and validation test plans, comparability protocols and Quality Expert Reports. He has developed extensive return on investment (ROI) models for rapid micro methods and will work with your senior management and finance groups to gain approval for RMM implementation. Dr. Miller provides an in-depth understanding of FDA and EMEA regulatory expectations for RMM validation and implementation, and can act as your liaison when meeting with regulatory agencies and competent authorities.
Working directly with RMM innovators, start-up companies and global RMM suppliers, Dr. Miller provides technical, regulatory, marketing, sales, business and strategic direction during the design and commercialization of next generation microbiology technologies.
Venture Capital firms interested in early-stage, high-potential companies often look toward experts with technology backgrounds, business training and deep industry experience to help guide them in understanding the long-term potential for their investments. Dr. Miller has experience in assisting a number of VC firms in providing commercialization, strategic and technical direction when considering investing in rapid microbiology opportunities.
Companies find that in-house training is the most cost-effective means to improve the skills and capabilities of their employees. Dr. Miller routinely delivers his RMM training course at global microbiology and manufacturing conferences. Now you can have him teach his course in your own facility without the fear of asking confidential questions regarding your products or processes.
A comprehensive, intensive and interactive two or one-day training course can be tailored to your company's needs. An example two-day syllabus is provided below: